Clinical Trials in Maryland

Showing 7881-7900 of 23,284 trials

Molecular Guided Therapy for Refractory or Recurrent Neuroblastoma

NCT01355679

The purpose of this study is to test the feasibility (ability to be done) of an experimental test to help plan your cancer treatment. This study plan is not studying the effectiveness of the proposed combinations of therapy for your cancer that you may receive after the experimental testing. This study will look at an experimental technology to determine a tumor's molecular makeup (gene expression profile). This technology (called "OncInsights") is being used to discover new ways to understand cancers and potentially predict the best treatments for patients with cancer in the future. The experimental technology has not been approved by the U.S. Food and Drug Administration.

Neuroblastoma

Giselle Sholler16 participantsStarted May 2011

Hartford, Connecticut, United States • Orlando, Florida, United States • Bethesda, Maryland, United States +4 more locations

COMPLETEDPhase 219 miles

Study of CRS-207, Nivolumab, and Ipilimumab With or Without GVAX Pancreas Vaccine (With Cy) in Patients With Pancreatic Cancer

NCT03190265

The purpose of this study is to study the safety and clinical activity of nivolumab and ipilimumab in combination with either sequential administration of CY/GVAX pancreas vaccine followed by CRS-207 (Arm A) or with administration of CRS-207 alone (Arm B) in patients with pancreatic cancer.

Pancreatic Cancer

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins61 participantsStarted Dec 2017

Baltimore, Maryland, United States

Molecular Guided Therapy for Refractory or Recurrent Neuroblastoma

Study of CRS-207, Nivolumab, and Ipilimumab With or Without GVAX Pancreas Vaccine (With Cy) in Patients With Pancreatic Cancer

Find Trials by Condition in Maryland

Exercise Effect on Chemotherapy-Induced Neuropathic Pain

Hypertrophic Cardiomyopathy Federated Learning Implementation Platform

Regadenoson Infusion of Marginalized Donor Lungs in an EVLP System

Preventative Trial of Difluoromethylornithine (DFMO) in High Risk Patients With Neuroblastoma That is in Remission

Optina Diagnostics' Cerebral ß-Amyloid Status (CAS) Test

Efficacy, Safety, and Tolerability of Gebasaxturev (V937) Administered Intravenously or Intratumorally With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone in Participants With Advanced/Metastatic Melanoma (V937-011)

ACY-1215 for Relapsed/Refractory Lymphoid Malignancies

Safety, Tolerability, and Pharmacokinetic (PK) Study of DHES0815A in Participants With Human Epidermal Growth Factor Receptor (HER)2-Positive Breast Cancer

A Placebo-controlled Study of Volixibat in Subjects With Elevated Serum Bile Acids Associated With Intrahepatic Cholestasis of Pregnancy (OHANA)

Randomized Efficacy Study of TPI 287 to Treat Primary Refractory or Early Relapsed Neuroblastoma

Safety and Efficacy Study of TPI-287 in Neuroblastoma and Medulloblastoma

Safety Study for Refractory or Relapsed Neuroblastoma With DFMO Alone and in Combination With Etoposide

TPI 287 in Patients With Refractory or Recurrent Neuroblastoma or Medulloblastoma

An Open-Label Extension Study to Evaluate Safety & Tolerability of QR-421a in Subjects With Retinitis Pigmentosa

Endpoint Determination Study Protocol

Training for Health Professionals In Tanzania

Microwave Treatment for Actinic Keratosis

Empowering Adolescents to Lead Change Using Health Data